InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

CRISPR Therapeutics AG

CRSP Clue Score37
Switzerland Fiscal year ends December CIK 0001674416 Results filed 2 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
Samarth Kulkarni
22 Jan 2026
Chief Executive Officer
Sold on a plan
60,000
$60.23
$3.61M
Samarth Kulkarni
20 Jan 2026
Chief Executive Officer
Sold on a plan
8,567
$52.10
$446.34K
Samarth Kulkarni
20 Jan 2026
Chief Executive Officer
Sold on a plan
21,433
$51.61
$1.11M
Raju Prasad
22 Dec 2025
Chief Financial Officer
Sold on a plan
1,000
$56.89
$56.89K
Raju Prasad
22 Dec 2025
Chief Financial Officer
Sold on a plan
5,472
$56.33
$308.26K
Raju Prasad
22 Dec 2025
Chief Financial Officer
Sold on a plan
3,528
$55.10
$194.40K
Samarth Kulkarni
19 Feb 2025
Chief Executive Officer
Sold on a plan
6,928
$52.80
$365.80K
Samarth Kulkarni
19 Feb 2025
Chief Executive Officer
Sold on a plan
18,360
$55.21
$1.01M
Samarth Kulkarni
2 Dec 2024
Chief Executive Officer
Sold on a plan
15,000
$55.10
$826.56K
Samarth Kulkarni
11 Nov 2024
Chief Executive Officer
Sold on a plan
6,879
$56.27
$387.08K
Samarth Kulkarni
11 Nov 2024
Chief Executive Officer
Sold on a plan
23,121
$55.43
$1.28M
Showing 250 of 546 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 439
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 196
Sales at will 315
Transactions with no price 0
Shares from compensation/vesting 20,354,169
Sales filed before the plan box existed 276
History held since 20 Oct 2016